K. L. N. Blocka

Clinical pharmacokinetics of piroxicam.

Roger K. Verbeeck, C. J. Richardson, K. L. N. Blocka · PubMed · 1986 · 49 citations

Translational Medicine, Pharmaceutical Science, Elderly Patients +10

High-performance liquid chromatographic analysis of piroxicam and its major metabolite 5′-hydroxypiroxicam in human plasma and urine

C. J. Richardson, Sharon G. Ross, K. L. N. Blocka et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1986 · 38 citations

Pharmaceutical Science, Biochemistry, Medicine +11

Single dose pharmacokinetics of auranofin in rheumatoid arthritis.

K. L. N. Blocka, D.E. Furst, Elliot M. Landaw et al. · PubMed · 1982 · 36 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +14

Piroxicam and 5?-hydroxypiroxicam kinetics following multiple dose administration of piroxicam

C. J. Richardson, K. L. N. Blocka, S. Ross et al. · European Journal of Clinical Pharmacology · 1987 · 23 citations

Pharmacological Study, Pharmacology, -Hydroxypiroxicam Kinetics +6

The effect of age on piroxicam disposition in rheumatoid arthritis.

K. L. N. Blocka, C. J. Richardson, Sylvia M. Wallace et al. · PubMed · 1988 · 14 citations

Inflammation, Rheumatology, Clinical Status +15